Thermo Fisher Partners with Datavant to Boost Real-World Data Linkage in Clinical Research
Event summary
- Thermo Fisher Scientific has entered a strategic data collaboration with Datavant to enhance real-world data (RWD) interoperability and linkage for clinical research.
- The partnership leverages Datavant’s tokenization technology to securely connect de-identified research datasets across over 350 RWD partners and 80,000 U.S. hospitals and clinics.
- Thermo Fisher’s PPD™ clinical research business will integrate Datavant’s encrypted token technology into its RWD infrastructure to improve study design, recruitment, and evidence generation.
- The collaboration follows Thermo Fisher’s broader investments in digital innovation, including a strategic partnership with OpenAI.
The big picture
This partnership underscores the growing emphasis on real-world data in clinical research, as biopharmaceutical companies seek faster and more efficient ways to generate evidence. Thermo Fisher’s collaboration with Datavant aligns with broader industry trends toward digital transformation and AI-driven insights, positioning the company to strengthen its leadership in RWE and observational study services.
What we're watching
- Data Integration Pace
- How quickly Thermo Fisher and Datavant can scale their data linkage capabilities across the broader life sciences industry.
- Competitive Response
- Whether competitors in clinical research and RWD analytics will accelerate similar partnerships to keep pace with this collaboration.
- Regulatory Compliance
- The extent to which privacy-preserving data connectivity can meet evolving regulatory standards for patient data usage.
Our editorial coverage:
Related topics